Patents Assigned to Tikcro Technologies Ltd.
  • ANTIBODIES SPECIFIC TO CTLA-4 AND USES THEREOF
    Publication number: 20230132385
    Abstract: Disclosed herein are anti-CTLA-4 antibodies possessing superior binding and biological activities relative to ipibmumab and tremelimumab, pharmaceutical compositions comprising such. Also provided herein are therapeutic and diagnostic applications of such anti-CTLA-4 antibodies.
    Type: Application
    Filed: September 20, 2019
    Publication date: April 27, 2023
    Applicants: Tikcro Technologies Ltd., Yeda Research and Development Co. Ltd.
    Inventors: Ami Navon, Aviv Boim, Ariel Stanhill, Leehee Weinberger, Yuval Avnir
  • ANTIBODIES SPECIFIC TO CTLA-4 AND USES THEREOF
    Publication number: 20210355220
    Abstract: Disclosed herein are anti-CTLA-4 antibodies possessing superior binding and biological activities relative to ipibmumab and tremelimumab, pharmaceutical compositions comprising such. Also provided herein are therapeutic and diagnostic applications of such anti-CTLA-4 antibodies.
    Type: Application
    Filed: September 20, 2019
    Publication date: November 18, 2021
    Applicants: Tikcro Technologies Ltd., Yeda Research and Development Co. Ltd.
    Inventors: Ami Navon, Aviv Boim, Ariel Stanhill, Leehee Weinberger, Yuval Avnir